The estimated Net Worth of Erica L Mann is at least $939 Mille dollars as of 14 May 2024. Ms. Mann owns over 8,764 units of Perrigo plc stock worth over $579,105 and over the last 6 years she sold PRGO stock worth over $0. In addition, she makes $359,548 as Independent Director at Perrigo plc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ms. Mann PRGO stock SEC Form 4 insiders trading
Erica has made over 5 trades of the Perrigo plc stock since 2020, according to the Form 4 filled with the SEC. Most recently she exercised 8,764 units of PRGO stock worth $264,848 on 14 May 2024.
The largest trade she's ever made was exercising 8,764 units of Perrigo plc stock on 14 May 2024 worth over $264,848. On average, Erica trades about 2,333 units every 97 days since 2019. As of 14 May 2024 she still owns at least 21,665 units of Perrigo plc stock.
You can see the complete history of Ms. Mann stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Erica Mann biography
Erica Lilith Mann serves as Independent Director of the Company. She has been a director of Perrigo since April 2019. Ms. Mann is a seasoned pharmaceutical executive. She served as President of Bayer’s Consumer Health Division from 2011 until March 2018. Prior to this Ms. Mann was the President of Pfizer’s Global Nutrition Division from 2009 until 2011 and with the Wyeth Group from 1994 until 2009, where she held various senior executive positions. Ms. Mann has served as a non-executive director of Kellogg since February 2019, and has served as a non-executive director of DSM, a global Nutrition, Health and Sustainable Living company, since May 2019. She previously served as director of SOHO Flordis International from August 2018 until November 2019 and Bayer AG from 2016 until March 2018 and as the chair of the World Self Medication Industry Association (Geneva, Switzerland) from 2011 until March 2018. She has held executive positions in several industry organizations, including the South African Pharmaceutical Manufacturers’ Association, Medicines Australia, and the International Association of Infant Food Manufacturers.
What is the salary of Erica Mann?
As the Independent Director of Perrigo plc, the total compensation of Erica Mann at Perrigo plc is $359,548. There are 19 executives at Perrigo plc getting paid more, with Murray Kessler having the highest compensation of $10,807,800.
How old is Erica Mann?
Erica Mann is 61, she's been the Independent Director of Perrigo plc since 2019. There are 9 older and 17 younger executives at Perrigo plc. The oldest executive at Perrigo Company plc is Rolf Classon, 75, who is the Independent Director.
What's Erica Mann's mailing address?
Erica's mailing address filed with the SEC is PERRIGO COMPANY PLC, 515 EASTERN AVENUE, ALLEGAN, MI, 49010.
Insiders trading at Perrigo plc
Over the last 11 years, insiders at Perrigo plc have traded over $21,020,805 worth of Perrigo plc stock and bought 592,512 units worth $38,708,035 . The most active insiders traders include Jeffrey C Smith, Gary M Cohen e Joseph C Papa. On average, Perrigo plc executives and independent directors trade stock every 11 days with the average trade being worth of $156,424. The most recent stock trade was executed by Ronald Craig Janish on 26 August 2024, trading 13,000 units of PRGO stock currently worth $382,200.
What does Perrigo plc do?
perrigo company plc, a top five global over-the-counter (otc) consumer goods and pharmaceutical company, offers consumers and customers high quality products at affordable prices. from its beginnings in 1887 as a packager of generic home remedies, perrigo, headquartered in ireland, has grown to become the world's largest manufacturer of otc products and supplier of infant formulas for the store brand market. the company is also a leading provider of branded otc products, generic extended topical prescription products and receives royalties from multiple sclerosis drug tysabri®. perrigo provides “quality affordable healthcare products®” across a wide variety of product categories and geographies primarily in north america, europe, and australia, as well as other key markets including israel and china. visit perrigo online at (http://www.perrigo.com).
What does Perrigo plc's logo look like?
Complete history of Ms. Mann stock trades at Kellanova Co e Perrigo plc
Perrigo plc executives and stock owners
Perrigo plc executives and other stock owners filed with the SEC include:
-
Murray Kessler,
President, Chief Executive Officer, Director -
Raymond Silcock,
Chief Financial Officer, Executive Vice President -
Murray S. Kessler,
CEO, Pres & Director -
Todd Kingma,
Executive Vice President, General Counsel, Company Secretary -
James Dillard,
Executive Vice President, Chief Scientific Officer -
Svend Andersen,
Executive Vice President, President - Consumer Healthcare International -
Sharon Kochan,
Executive Vice President, President - RX Pharmaceuticals -
Raymond P. Silcock,
CFO, Principal Accounting Officer & Exec. VP -
Svend Andersen,
Exec. VP & Pres of Consumer Healthcare International -
Richard S. Sorota,
Exec. VP & Pres of Consumer Self-Care Americas -
Todd W. Kingma,
Exec. VP, Gen. Counsel & Sec. -
James E. Dillard III,
Exec. VP & Pres of Consumer Self-Care Americas -
Rolf Classon,
Independent Director -
Donal O'Connor,
Independent Director -
Jeffrey Kindler,
Independent Director -
Theodore Samuels,
Independent Director -
Geoffrey Parker,
Independent Director -
Bradley Alford,
Independent Director -
Adriana Karaboutis,
Independent Director -
Erica Mann,
Independent Director -
Bradley Joseph,
Vice President Global Investor Relations -
Katherine Doyle,
Director -
Rich Sorota,
Executive Vice President and President - Consumer Self-Care Americas -
Grainne Quinn,
Executive Vice President, Chief Medical Officer -
Ronald Janish,
Executive Vice President - Global Operations and Supply Chain, Chief Transformation Officer -
Thomas Farrington,
Executive Vice President, Chief Information Officer -
Robert Willis,
Chief Human Resource Officer, Executive Vice President -
Kyle L. Hanson,
Exec. VP, Gen. Counsel & Corp. Sec. -
Alison Ives,
Exec. VP & Chief Scientific Officer -
Eduardo Guarita Bezerra,
Exec. VP & CFO -
Mary Reilly-Brest,
Director of Global Organizational and Human Resource Devel. -
Thomas M. Farrington,
Chief Information Officer & Exec. VP -
Shannon Hukill,
Sr. Director of Technical Operations -
Ronald C. Janish,
Chief Transformation Officer and Exec. VP of Global Operations & Supply Chain -
Patrick Lockwood Taylor,
CEO -
Paul Weninger,
EVP, Quality Operations -
James R Michaud,
EVP, Chief HR Officer -
John T Hendrickson,
EVP Global Operations & Supply -
Gary M Cohen,
Director -
John Wesolowski,
EVP, President Rx -
Michael J Jandernoa,
Director -
Judy L Brown,
Executive VP & CFO -
Laurie Brlas,
Director -
Jeffrey C Smith,
Director -
Triona Schmelter,
EVP & President CSCA -
Uwe Roehrhoff,
CEO -
Ronald Winowiecki,
CFO -
David Ball,
EVP & CBDO -
Jacqualyn A Fouse,
Director -
Ellen Randi Hoffing,
Director -
Louis Yu,
Executive VP Global Quality -
Shlomo Yanai,
Director -
Marc Coucke,
Executive VP & GM -
Michael Robert Stewart,
Sr. VP Global Human Resources -
Joseph C Papa,
President and CEO -
Gary K Jr Kunkle,
Director -
Herman Jr Morris,
Director -
Ben Zion Zilberfarb,
Director -
Ran Gottfried,
Director -
Jatin Shah,
Sr VP & Chief Scientific Offic -
Scott F Jamison,
-
David T Gibbons,
Director -
Douglas Boothe,
EVP & GM Perrigo Pharma -
Jeffrey Needham,
EVP, President CHC Americas -
Orlando D Ashford,
Director -
Alison Ives,
EVP & Chief Scientific Officer -
Kyle Hanson,
EVP & General Counsel -
Eduardo Guarita Bezerra,
EVP & Chief Financial Officer -
Albert Manzone,
Director -
Julia M Brown,
Director